Page last updated: 2024-11-04

terfenadine and Experimental Radiation Injuries

terfenadine has been researched along with Experimental Radiation Injuries in 1 studies

Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.

Research Excerpts

ExcerptRelevanceReference
"Terfenadine, given in sufficient dose to cause maximum H1 receptor blockade, had no effect on the intensity of UVB or UVC erythema measured with a reflectance instrument at 4, 8, and 24 h after irradiation."9.06A quantitative study of the effect of terfenadine on cutaneous erythema induced by UVB and UVC radiation. ( Diffey, BL; Farr, PM; Humphreys, F, 1986)
"Terfenadine, given in sufficient dose to cause maximum H1 receptor blockade, had no effect on the intensity of UVB or UVC erythema measured with a reflectance instrument at 4, 8, and 24 h after irradiation."5.06A quantitative study of the effect of terfenadine on cutaneous erythema induced by UVB and UVC radiation. ( Diffey, BL; Farr, PM; Humphreys, F, 1986)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Farr, PM1
Diffey, BL1
Humphreys, F1

Trials

1 trial available for terfenadine and Experimental Radiation Injuries

ArticleYear
A quantitative study of the effect of terfenadine on cutaneous erythema induced by UVB and UVC radiation.
    The Journal of investigative dermatology, 1986, Volume: 87, Issue:6

    Topics: Adult; Animals; Benzhydryl Compounds; Dose-Response Relationship, Radiation; Erythema; Female; Hista

1986